In recent trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 0.42 million shares changing hands at last check today with its beta currently measuring 0.95. Company’s recent per share price level of $1.97 trading at $0.03 or 1.55% at last check today assigns it a market valuation of $105.32M. That most recent trading price of MIST’s stock is at a discount of -39.59% from its 52-week high price of $2.75 and is indicating a premium of 68.02% from its 52-week low price of $0.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.56 million shares which gives us an average trading volume of 1.93 million if we extend that period to 3-months.
For Milestone Pharmaceuticals Inc (MIST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Upright in the green today for gaining 1.55%, in the last five days MIST remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $1.97 price level, adding 2.48% to its value on the day. Milestone Pharmaceuticals Inc’s shares saw a change of 52.71% in year-to-date performance and have moved 16.57% in past 5-day. Milestone Pharmaceuticals Inc (NASDAQ:MIST) showed a performance of 29.61% in past 30-days. Number of shares sold short was 2.01 million shares which calculate 2.67 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 80.3% to its recent value today. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -407.61% in reaching the projected high whereas dropping to the targeted low would mean a loss of -407.61% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.21% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -20.52% while estimates for its earnings growth in next 5 years are of 9.29%.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Insiders are in possession of 4.71% of company’s total shares while institution are holding 22.25 percent of that, with stock having share float percentage of 23.35%. Investors also watch the number of corporate investors in a company very closely, which is 22.25% institutions for Milestone Pharmaceuticals Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at MIST for having 4.97 million shares of worth $6.56 million. And as of 2024-06-30, it was holding 7.5135 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 3.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9211 of outstanding shares, having a total worth of $4.3 million.
